Key Highlights

● SEC Effectiveness: The SEC declared effective the Form 10 registration statement for Vylor, Corteva's seed and genetics Business being spun off.

● Distribution Ratio: Corteva shareholders receive one Vylor share for every Corteva share held as of the September 24, 2026 record date.

● Trading Start: Vylor begins regular trading on the NYSE under ticker VYLR before the market opens October 1, 2026.

● No Action Needed: Corteva shareholders do not need to take any action or make any payment to receive their Vylor shares.

Corteva, Inc. (NYSE:CTVA) filed an 8-K September 25 confirming that the Securities and Exchange Commission has declared effective the Form 10 registration statement for Vylor, the seed and genetics business Corteva is spinning off into a standalone public company. Corteva shareholders will receive one share of Vylor common stock for every Corteva share they hold as of a September 24, 2026 record date, with the separation expected to be completed and Vylor shares distributed before the market opens October 1, 2026, when the new company begins regular trading on the NYSE under the ticker VYLR.

What the Filing Discloses

The 8-K was filed jointly by Corteva, Inc. and its Subsidiary EIDP, Inc., both of which have securities registered with the SEC: Corteva's common stock trades under CTVA, while EIDP's $3.50 Series Preferred Stock A and B trade under CTAPrA and CTAPrB, all on the NYSE. The filing states that a press release dated September 24, 2026, announcing the Form 10 effectiveness and the details of the distribution, is attached as Exhibit 99.1. Jennifer A. Johnson, Corteva's Senior Vice President, Chief Legal and Public Affairs Officer and Corporate Secretary, signed the filing on behalf of both entities September 25, 2026.

The Mechanics of the Spin-Off

A Form 10 is the registration statement companies use to list a class of securities, such as those of a newly spun-off subsidiary, without conducting a traditional initial public offering; SEC effectiveness of that registration is a required step before a distribution of shares to existing shareholders can proceed. With the Form 10 now effective, Corteva said the distribution ratio is one Vylor share for every Corteva share held on the record date, and that there will be no when-issued or ex-distribution trading in Vylor shares before the distribution itself takes place.

The companies said the separation is expected to be completed, with shares distributed, prior to 9:30 a.m. Eastern Time on October 1, 2026, the same day Vylor begins regular-way trading on the NYSE. Corteva shareholders do not need to take any action or make any payment to receive their Vylor shares under this exchange-based distribution structure.

How the Two Companies Describe Themselves

Corteva describes itself as “a global pure-play agriculture company,” combining what it calls innovation, customer engagement and operational execution across seed, crop protection and digital agriculture products and services under established brands. Vylor, the business being spun out, characterizes itself as “an advanced seed and genetics company” built on more than a century of focus on farmer innovation, emphasizing elite germplasm, biotechnology expertise and an expanding licensing business intended to boost global crop yields.

What the Filing Does Not Say

The 8-K and accompanying materials reviewed do not disclose Vylor's projected standalone revenue, employee count, or its initial capital structure, including whether it will carry any Debt at separation. The filing also does not detail Corteva's remaining business mix once the seed and genetics operations are separated, nor does it specify any transition services agreement that might govern the relationship between the two companies after October 1.

Vylor's First Days as a Standalone Company

The distribution is expected to be completed before markets open October 1, 2026, when Vylor shares begin trading on the NYSE under VYLR; investors should watch for confirmation that the separation closed on schedule and for Vylor's first public financial disclosures as an independent registrant, which would typically follow in a subsequent periodic filing.